Diabetic Peripheral Neuropathy
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Diagnosed with diabetes mellitus; 2. The patient was diagnosed with distal symmetrical polyneuropathy of diabetes mellitus, and related symptoms had been present for more than 6 months; 3. Aged 18-75 years; 4. Total Symptom Score (TSS) of diabetic distal symmetric multiple neuropathy >= 5 points; 5. Have not received drug treatment for diabetic distal symmetrical polyneuropathy in the past 1 month, have not received acupuncture treatment in the past 3 months, and have not participated in other ongoing clinical studies; 6. Sign informed consent to participate in the study voluntarily.
Exclusion criteria
Exclusion criteria: 1. Glycosylated hemoglobin > 10%; 2. Implantation of a pacemaker; 3. Pregnancy, lactation or planned pregnancy; 4. Patients with malignant tumors or chemotherapy, severe cardiovascular and cerebrovascular diseases, infectious diseases, vitamin B12 deficiency, cervical and lumbar spine diseases, hereditary neuropathy, liver and kidney insufficiency; Alcoholism; 5. Have a history of cerebral hemorrhage, inherited hemorrhagic disease (such as hemophilia), or are using anticoagulant drugs such as warfarin; 6. Foot ulcer or gangrene; 7. Patients with cognitive dysfunction, aphasia, or mental disorders cannot cooperate with this study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Total symptom score; | — |
Secondary
| Measure | Time frame |
|---|---|
| Numeric rating scale for pain intensity;12-item short-form health survey;Treatment expectancy;Adverse events;Nerve conduction velocity;Response rate for Total Symptom Score;Total symptom score; | — |
Countries
China
Contacts
Beijing University of Chinese Medicine